NL165162C - Werkwijze ter bereiding van een geneesmiddel met anti- bacteriele werking, gevormd geneesmiddel, alsmede werk- wijze ter bereiding van gesubstitueerde nitrofuryl- acrylideenhydrazineverbindingen. - Google Patents
Werkwijze ter bereiding van een geneesmiddel met anti- bacteriele werking, gevormd geneesmiddel, alsmede werk- wijze ter bereiding van gesubstitueerde nitrofuryl- acrylideenhydrazineverbindingen.Info
- Publication number
- NL165162C NL165162C NL7200284.A NL7200284A NL165162C NL 165162 C NL165162 C NL 165162C NL 7200284 A NL7200284 A NL 7200284A NL 165162 C NL165162 C NL 165162C
- Authority
- NL
- Netherlands
- Prior art keywords
- medicinal product
- preparing
- acrylideen
- nitrofuryl
- hydrazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/70—Nitro radicals
- C07D307/71—Nitro radicals attached in position 5
- C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
- C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
- C07D307/75—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals having carboxylic acyl radicals or their thio or nitrogen analogues directly attached to the hydrazino or hydrazono radical, e.g. hydrazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
- C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7100283A FR2121372B1 (es) | 1971-01-07 | 1971-01-07 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7200284A NL7200284A (es) | 1972-07-11 |
| NL165162B NL165162B (nl) | 1980-10-15 |
| NL165162C true NL165162C (nl) | 1981-03-16 |
Family
ID=9069895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7200284.A NL165162C (nl) | 1971-01-07 | 1972-01-07 | Werkwijze ter bereiding van een geneesmiddel met anti- bacteriele werking, gevormd geneesmiddel, alsmede werk- wijze ter bereiding van gesubstitueerde nitrofuryl- acrylideenhydrazineverbindingen. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3847911A (es) |
| JP (2) | JPS573674B1 (es) |
| BE (1) | BE777759A (es) |
| CA (1) | CA966126A (es) |
| CH (2) | CH546755A (es) |
| DE (1) | DE2200375C2 (es) |
| DO (1) | DOP1984004201A (es) |
| FR (1) | FR2121372B1 (es) |
| GB (1) | GB1367203A (es) |
| IL (1) | IL38519A (es) |
| MY (1) | MY7700078A (es) |
| NL (1) | NL165162C (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU71111A1 (es) * | 1974-10-15 | 1976-08-19 | ||
| JPS6182678U (es) * | 1984-11-07 | 1986-05-31 | ||
| DE4011172A1 (de) * | 1990-04-06 | 1991-10-10 | Degussa | Verbindungen zur bekaempfung von pflanzenkrankheiten |
| US7786139B2 (en) * | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
-
1971
- 1971-01-07 FR FR7100283A patent/FR2121372B1/fr not_active Expired
-
1972
- 1972-01-05 US US00215677A patent/US3847911A/en not_active Expired - Lifetime
- 1972-01-05 DE DE2200375A patent/DE2200375C2/de not_active Expired
- 1972-01-06 CH CH1535973A patent/CH546755A/fr not_active IP Right Cessation
- 1972-01-06 BE BE777759A patent/BE777759A/xx not_active IP Right Cessation
- 1972-01-06 GB GB68572A patent/GB1367203A/en not_active Expired
- 1972-01-06 IL IL38519A patent/IL38519A/xx unknown
- 1972-01-06 CH CH16972A patent/CH549565A/fr not_active IP Right Cessation
- 1972-01-06 CA CA131,854A patent/CA966126A/en not_active Expired
- 1972-01-06 JP JP422472A patent/JPS573674B1/ja active Pending
- 1972-01-07 NL NL7200284.A patent/NL165162C/xx not_active IP Right Cessation
-
1977
- 1977-12-30 MY MY78/77A patent/MY7700078A/xx unknown
-
1980
- 1980-06-05 JP JP7502680A patent/JPS5663978A/ja active Granted
-
1984
- 1984-02-03 DO DO1984004201A patent/DOP1984004201A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3847911A (en) | 1974-11-12 |
| FR2121372B1 (es) | 1974-03-22 |
| JPS573674B1 (es) | 1982-01-22 |
| JPS5734276B2 (es) | 1982-07-22 |
| FR2121372A1 (es) | 1972-08-25 |
| CA966126A (en) | 1975-04-15 |
| MY7700078A (en) | 1977-12-31 |
| NL165162B (nl) | 1980-10-15 |
| CH549565A (fr) | 1974-05-31 |
| GB1367203A (en) | 1974-09-18 |
| CH546755A (fr) | 1974-03-15 |
| DE2200375C2 (de) | 1984-08-09 |
| NL7200284A (es) | 1972-07-11 |
| IL38519A0 (en) | 1972-03-28 |
| IL38519A (en) | 1975-03-13 |
| DE2200375A1 (de) | 1972-10-19 |
| BE777759A (es) | 1972-07-06 |
| JPS5663978A (en) | 1981-05-30 |
| DOP1984004201A (es) | 1989-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL162398C (nl) | Werkwijze voor de bereiding van een entcopolymeer en gevormd voortbrengsel. | |
| NL170147C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat, gevormd preparaat daarvan en heterocyclische diaminen hiervoor. | |
| NL174550C (nl) | Werkwijze ter bereiding van een lactatieremmende verbinding, werkwijze voor het bereiden van een geneesmiddel met lactatieremmende werking en gevormd geneesmiddel. | |
| NL163788C (nl) | Werkwijze ter bereiding van een geneesmiddel met neuro- trope en psychotrope werking, alsmede werkwijze voor het bereiden van een geneeskrachtig dibenzothiepien of dibenzooxepienderivaat. | |
| NL179739C (nl) | Werkwijze ter bereiding van organopolysiloxansamenstellingen, alsmede gevormd voortbrengsel. | |
| NL164271C (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat met een werking tegen tumoren en leukemie. | |
| NL149834B (nl) | Werkwijze ter bereiding van een thermoplastisch preparaat, alsmede daaruit vervaardigd gevormd voortbrengsel. | |
| NL177386B (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat met anti-allergische werking. | |
| NL146819B (nl) | Werkwijze ter bereiding van een geneesmiddel met antibacteriele werking, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen. | |
| NL156710B (nl) | Werkwijze ter bereiding van sorptiemiddelen, alsmede gevormde sorptiemiddelen bereid volgens deze werkwijze. | |
| NL164041C (nl) | Werkwijze ter bereiding van een 4,6-dichloor-17alfa -ethynyl-4,6-oestradieenderivaat met progestatieve werking, alsmede werkwijze ter bereiding van farma- ceutisch preparaat en gevormd preparaat. | |
| NL160550C (nl) | Werkwijze ter bereiding van insekticide en acaricide pre- paraten, gevormde preparaten en werkwijze ter bereiding van verbindingen met insekticide en acaricide werking. | |
| NL166470C (nl) | Werkwijze ter bereiding van een geneesmiddel met bronchi-verwijdende en de afscheiding van maagzuur tegengaande werking, alsmede werkwijze ter bereiding van daarin toegepaste pyrimidinonverbindingen. | |
| NL165162C (nl) | Werkwijze ter bereiding van een geneesmiddel met anti- bacteriele werking, gevormd geneesmiddel, alsmede werk- wijze ter bereiding van gesubstitueerde nitrofuryl- acrylideenhydrazineverbindingen. | |
| NL147036B (nl) | Werkwijze ter bereiding van een geneesmiddel met depressiebestrijdende of psychostimulerende werking, alsmede van hiertoe geschikte indaanderivaten. | |
| NL155015B (nl) | Werkwijze ter bereiding van een farmaceutisch of veterinair preparaat met anti-bacteriele werking, gevormd preparaat en werkwijze ter bereiding van chinolinederivaten, die een nitrofurylgroep bevatten. | |
| NL170527C (nl) | Werkwijze ter bereiding van 1,3-dichloorpropeen. | |
| NL161150C (nl) | Werkwijze voor het bereiden van een geneesmiddel, alsmede verkregen gevormd geneesmiddel en werkwijze voor het bereiden van een benzofuranverbinding. | |
| NL7408875A (nl) | Werkwijze voor de bereiding van alkalipolyfos- faatcomplexen met antibiotische werking, werk- wijze voor de bereiding van een geneesmiddel met een dergelijke werking en een dergelijk geneesmiddel. | |
| NL169179C (nl) | Werkwijze ter bereiding van een geneesmiddel met beta-adrenergisch stimulerende werking, gevormd geneesmiddel en werkwijze ter bereiding van ureidobenzylverbindingen. | |
| NL156125C (nl) | Werkwijze voor de bereiding van ethenische carbonyl- verbindingen. | |
| NL160565C (nl) | Werkwijze ter bereiding van een preparaat met analgetische werking, gevormd preparaat, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen. | |
| NL174663C (nl) | Werkwijze ter bereiding van kunstlederachtige, dunwandige gevormde voortbrengsels. | |
| NL7609652A (nl) | Werkwijze ter bereiding van een geneesmiddel met anti-bacteriele werking, zo gevormd ge- neesmiddel en werkwijze ter bereiding van daartoe geschikte geneeskrachtige verbindingen. | |
| NL153905B (nl) | Werkwijze ter bereiding van 2,4,5-triketoimidazolidinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |